IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms

Authors:

Abstract
Immunoglobulin E (IgE) activates mast cells (MCs). It remains unknown whether IgE also activates other inflammatory cells, and contributes to the pathogenesis of abdominal aortic aneurysms (AAAs). This study demonstrates that CD4 + T cells express IgE receptor FcεR1, at much higher levels than do CD8 + T cells. IgE induces CD4 + T‐cell production of IL6 and IFN‐γ, but reduces their production of IL10. FcεR1 deficiency ( Fcer1a −/− ) protects apolipoprotein E‐deficient ( Apoe −/− ) mice from angiotensin‐II infusion‐induced AAAs and reduces plasma IL6 levels. Adoptive transfer of CD4 + T cells (but not CD8 + T cells), MCs, and macrophages from Apoe −/− mice, but not those from Apoe −/− Fcer1a −/− mice, increases AAA size and plasma IL6 in Apoe −/− Fcer1a −/− recipient mice. Biweekly intravenous administration of an anti‐IgE monoclonal antibody ablated plasma IgE and reduced AAAs in Apoe −/− mice. Patients with AAAs had significantly higher plasma IgE levels than those without AAAs. This study establishes an important role of IgE in AAA pathogenesis by activating CD4 + T cells, MCs, and macrophages and supports consideration of neutralizing plasma IgE in the therapeutics of human AAAs.
Funding Information
  • National Institutes of Health (HL60942)
  • National Institutes of Health (HL81090)
  • National Institutes of Health (HL88547)
  • National Institutes of Health (HL34636)
  • National Institutes of Health (HL80472)
  • American Heart Association Established Investigator Award (0840118N)

This publication has 57 references indexed in Scilit: